Dr. Anthony Joshua completed his medical oncology training at the Royal Prince Alfred hospital in Sydney, Australia before moving to Toronto to complete a PhD under the supervision of Dr. Jeremy Squire in prostatic carcinogenesis. He has since joined the Department of Medical Oncology at Princess Margaret Hospital, specialising in genito-urinary malignancy and melanoma. He is currently an Assistant Professor with the University of Toronto and a clinician-scientist at the University Health Network.
Anthony Michael Joshua
His current research interests include the unfolded protein response (working with Dr. Brad Wouters), autophagy in prostatic carcinogenesis, translational research in GU and melanoma trials and clinical trial design. He also has an interest in epistemiology in medicine.
Cancer Res. 2017 Sep 15;:
Support Care Cancer. 2017 Jul 25;:
Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study.
Curr Oncol. 2017 Jun;24(3):168-175
Cancers (Basel). 2017 Apr 15;9(4):
Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity.
Cancer Chemother Pharmacol. 2017 Apr 04;:
Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS).
PLoS One. 2017;12(2):e0170544
What is the role of comorbidity, frailty, and functional status in the decision-making process for older adults with cancer and their family members, oncologists, and family physician?
J Clin Oncol. 2016 Jan 20;34(3_suppl):92
Curr Oncol. 2016 Dec;23(6):e563-e570
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.
J Cancer Res Clin Oncol. 2016 Dec 05;
Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking.
Nat Nanotechnol. 2016 Nov 21;:
Principal Investigator, Princess Margaret Cancer Centre
Assistant Professor, Department of Medicine, University of Toronto